| Literature DB >> 19196461 |
Hongbo Chen1, Changchun Li, Mingdi Fang, Mengjin Zhu, Xinyun Li, Rui Zhou, Kui Li, Shuhong Zhao.
Abstract
BACKGROUND: Haemophilus parasuis (HPS) is an important swine pathogen that causes Glässer's disease, which is characterized by fibrinous polyserositis, meningitis and arthritis. The molecular mechanisms that underlie the pathogenesis of the disease remain poorly understood, particularly the resistance of porcine immune system to HPS invasion. In this study, we investigated the global changes in gene expression in the spleen following HPS infection using the Affymetrix Porcine Genechip.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19196461 PMCID: PMC2660370 DOI: 10.1186/1471-2164-10-64
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Primers used for QPCR evaluation on cell migrations
| Gene | Marker for cell types | Primer sequence (5'-3') | Target size (bp) | Tm (°C)a |
| T cell | Forward: TGTGGTTTCAGCAGCCAAGAG | 130 | 59.8 | |
| Macrophage | Forward: CAACCTGGGTCAGAGGAAGC | 207 | 62 | |
| T cell | Forward: ACCTCTTAGTTCCTCCCTTTG | 137 | 59.8 | |
| Macrophage | Forward: GCAGAGGCTTTGAGGACCTTATC | 154 | 62 | |
| T cell | Forward: TCTGCGAAGTGGAAGACAAG | 179 | 59.8 | |
| Forward: CGGAAGTTTCTGGTACACAATGTAA | 94 | 59.8–62 |
aThe annealing temperature represents the optimal temperature during quantitative PCR. bRNA levels of RPL32 was assayed for normalization during quantitative PCR.
Figure 1QPCR evaluation on cell migrations in spleen following HPS infection. The same letter "a" above the bars for each marker suggested a no significant fold change between the controls and the infected spleens. Fold change is calculated based on the mean intensity value from 3 donors within each group by using the comparative Ct method. Significant levels (0.05) were analyzed by T-test.
Figure 2A hierarchical cluster of 258 transcripts following HPS infection in 30-day-old piglet spleen. Each row represents a separate transcript and each column represents a separate piglet. Color legend is on the left, red indicates increased transcript expression levels, whereas green indicates decreased levels compared with normal samples. Up-/down- regulated response transcripts are highlighted on the right with the No. in each cluster in parentheses. Fold change is calculated based on the mean intensity value from 3 donors within each group.
Figure 3Percentage distribution of unique genes from 258 differentially regulated transcripts after BLASTX searches and annotation. 158 unique genes had significant similarities based on BLASTX searches. 92 (70+22) unique genes had been annotated by Biology Process (BP) Classification. Percentage of each part was marked in the parentheses.
Figure 4Categories of 70 unique genes (FC≥2, . Many categories shared the same transcripts.
The 92 annotated genes in piglet spleen following HPS infectiona
| Functional classification | Gene Discriptionb | GenBank ID | FCc | |
| NM_020415 | ||||
| S100 calcium binding protein A9 | NM_002965 | 21.8 | 1.60E-03 | |
| S100 calcium binding protein A12 | NM_005621 | 16.6 | 1.29E-02 | |
| S100 calcium binding protein A8 | NM_002964 | 8.4 | 2.29E-02 | |
| NM_001276 | ||||
| NM_001003962 | ||||
| Interleukin 1 receptor accessory protein | NM_002182 | 4.6 | 6.00E-04 | |
| Complement component 3 | NM_000064 | 3.3 | 4.51E-02 | |
| Interleukin 10 receptor; beta | 2.8 | 3.47E-02 | ||
| Histone deacetylase 9 | 0.5 | 7.00E-04 | ||
| Chemokine (C-C motif) ligand 5 | 0.4 | 3.30E-03 | ||
| Serum amyloid A1 | 23.9 | 1.35E-02 | ||
| Lactotransferrin | 13.0 | 2.26E-02 | ||
| Angiotensinogen | 10.2 | 6.50E-03 | ||
| Haptoglobin | 10.0 | 1.36E-02 | ||
| Ceruloplasmin/ferroxidase | 4.9 | 4.09E-05 | ||
| CD163 antigen | 4.6 | 3.56E-02 | ||
| Lysozyme | 2.3 | 4.20E-03 | ||
| CD2 (cytoplasmic tail) binding protein 2 | 0.4 | 2.79E-02 | ||
| Transglutaminase 1 | 22.3 | 1.62E-02 | ||
| Serpin peptidase inhibitor, clade E, member 2 | 3.6 | 2.74E-02 | ||
| Secreted frizzled-related protein 1 | 2.3 | 3.23E-02 | ||
| Growth arrest and DNA-damage-inducible; gamma | 2.0 | 2.79E-02 | ||
| Carnitine deficiency-associated; expressed in ventricle 1 | 0.4 | 2.24E-02 | ||
| Myeloid leukemia factor 1 | 0.4 | 1.61E-02 | ||
| Stathmin-like 2 | 0.2 | 4.11E-02 | ||
| Mal; T-cell differentiation protein | 0.2 | 2.82E-02 | ||
| Claudin 3 | 9.7 | 2.34E-02 | ||
| CD44 antigen | 2.5 | 5.50E-03 | ||
| Immunoglobulin superfamily containing leucine-rich repeat | 2.3 | 3.44E-02 | ||
| Discs; large homolog 5 | 2.2 | 2.05E-02 | ||
| Thrombospondin 1 | 2.2 | 3.49E-02 | ||
| Collagen; type XV; alpha 1 | 2.0 | 1.03E-02 | ||
| Nephronophthisis 1 | 0.5 | 2.18E-02 | ||
| Nuclear receptor subfamily 3; group C; member 2 | 0.4 | 3.18E-02 | ||
| Fibronectin leucine rich transmembrane protein 3 | 0.4 | 3.62E-02 | ||
| PDZ domain containing 2 | 0.3 | 8.10E-03 | ||
| Superoxide dismutase 2; mitochondrial | 3.8 | 6.10E-03 | ||
| Dual specificity phosphatase 1 | 2.1 | 2.05E-02 | ||
| Transcobalamin I | 17.7 | 3.06E-02 | ||
| CCAAT/enhancer binding protein (C/EBP), beta | 3.1 | 3.00E-02 | ||
| Nuclear factor; interleukin 3 regulated | 2.3 | 4.70E-03 | ||
| Macrophage stimulating 1 | 2.9 | 3.31E-02 | ||
| Coagulation factor III | 2.8 | 1.74E-02 | ||
| Annexin A8 | 2.4 | 4.19E-02 | ||
| Coagulation factor XIII; A1 polypeptide | 2.4 | 4.59E-02 | ||
| GTP binding protein overexpressed in skeletal muscle | 3.6 | 1.73E-02 | ||
| Interleukin 4 receptor | 2.2 | 2.57E-02 | ||
| Major histocompatibility complex; class II; DR beta 1 | 0.5 | 4.18E-02 | ||
| Guanylate binding protein 1; interferon-inducible; 67 kDa | 0.5 | 8.70E-03 | ||
| DnaJ | 0.5 | 3.60E-03 | ||
| Pituitary tumor-transforming 1 | 0.5 | 5.00E-04 | ||
| Potassium voltage-gated channel; subfamily H | 0.5 | 4.33E-02 | ||
| Major histocompatibility complex; class I; B | 0.3 | 6.00E-04 | ||
| P8 protein | 5.4 | 1.57E-02 | ||
| Neuron navigator 1 | 3.4 | 1.92E-02 | ||
| apolipoprotein D | 2.6 | 8.00E-03 | ||
| Putative insulin-like growth factor II associated prote | 2.2 | 2.60E-03 | ||
| FYVE; RhoGEF and PH domain containing 4 | 2.2 | 4.74E-02 | ||
| 3-phosphoadenosine 5-phosphosulfate synthase 2 | 2.1 | 2.89E-02 | ||
| Epimorphin | 0.5 | 4.16E-02 | ||
| Chondrolectin | 0.5 | 2.66E-02 | ||
| Ecotropic viral integration site 5 | 0.5 | 1.52E-02 | ||
| SMAD; mothers against DPP homolog 5 | 0.5 | 4.20E-02 | ||
| Insulin-like growth factor 2 | 0.4 | 1.76E-02 | ||
| SRY | 0.4 | 4.06E-02 | ||
| Chromosome 11 open reading frame 8 | 0.4 | 3.25E-02 | ||
| Actin; alpha; cardiac muscle | 0.3 | 8.10E-03 | ||
| Cellular retinoic acid binding protein 1 | 0.1 | 4.34E-02 | ||
| Erythroid associated factor | 0.01 | 6.70E-03 | ||
| Arginase; type II | 2.1 | 1.41E-02 | ||
| Arginase; type I | 0.2 | 2.53E-02 | ||
| v-maf musculoaponeurotic fibrosarcoma oncogene homolog F | 5.2 | 2.00E-04 | ||
aUp/down-regulated genes which putative functions assigned based on GO term and manual annotation. Manual annotations were listed in italics. Many genes could be classified into multiple categories but only the most specific biology processes were listed. bTop informative BLASTX hit. cFold change, gene expression level following infection compared to the control. "≥2" represents up regulation (infection/control), "≤0.5" represents down regulation. d Significance level of differential expression for a particular gene.
Primers used for QPCR validation and additional expression profiling
| Gene | Primer sequence (5'-3') | Target size (bp) | Tm (°C)a |
| Forward: CCTCTTCCTCCCAACCCTG | 150 | 62 | |
| Forward: GGCATTATGACACCCTTATC | 168 | 60 | |
| Forward: CCAGGATGTGGTTTATGGCTTTC | 186 | 60 | |
| Forward: TTACCAGTGCCTCTCCTCCAT | 127 | 60 | |
| Forward: TTCCCGCCCACCATTACC | 121 | 60 | |
| Forward: ACTCCACGGTAGACATCGG | 149 | 63 | |
| Forward: GCGTAGATGGCGTGGTAA | 155 | 60 | |
| Forward: CGGCTATTCGTCCTCTTTGTT | 102 | 60 | |
| Forward: CCTGAGACAGCCCGTGGAT | 141 | 60 | |
| Forward: GCCCTTCTTCCAACCAATCA | 172 | 60 | |
| Forward: CGGAAGTTTCTGGTACACAATGTAA | 94 | 60–63 |
aThe annealing temperature represents the optimal temperature during quantitative PCR. bHPS infection related factor; No significant similarity was found after BLASTX searches and we named this gene ourselves. cRNA levels of RPL32 was assayed for normalization during quantitative PCR.
Figure 5Validation of the microarray data by QPCR analyses. RETN, S100A12, S100A9, HIRF, CFP, HP, S100A8, and THY (A) were up regulated in HPS infected piglets (light gray bars) compared with normal controls (black bars), CCL5 and ERAF (B) were down regulated. Fold change is calculated based on the mean intensity value from 3 donors within each group by using the comparative Ct method. Significant levels were analyzed by T-test. **, p ≤ 0.01; *, p ≤ 0.05.
A validation of microarray data by QPCR
| Gene | GenBank ID | Microarray FC | QPCR FC | |
| +a 25.9 | +55.3 | 9.E-03 | ||
| +16.6 | +48.9 | 2.E-02 | ||
| +21.8 | +26.7 | 8.E-03 | ||
| +111.4 | +41.0 | 1.E-03 | ||
| +1.6 | +5.6 | 9.E-03 | ||
| +10.0 | +4.8 | 5.E-02 | ||
| +8.4 | +5.9 | 3.E-02 | ||
| +1.6 | +2.2 | 8.E-03 | ||
| -b 2.5 | -2.5 | 2.E-02 | ||
| -100.0 | -39.9 | 1.E-02 |
aRepresents up regulation. bRepresents down regulation.
Figure 6Kinetic immune stimuli analyses challenged by LPS(A-D) and Poly(I:C)(E-F) in PK-15 cells. S100A8(A, E), S100A9(B, F), S100A12(C, G), and HP(D, H). PK-15 cells were treated with 1 μg/mL LPS and 10 μg/mL Poly(I:C) respectively. QPCR was performed using primers described in Table 3. Results are from the calculated average ± SD of three different cell samples in the same treatment. The significance of differences for the expression compared to the untreated control was calculated using two-directional paired Student's T-test. **, p ≤ 0.01; *, p ≤ 0.05.
Figure 7Genes that distributed in the known pig QTLs of Health Traits. WBC, White Blood Cell Counts; ECF18R, Small Intestinal Escherichia Coli F18 Receptor; PRV, Resistance/Susceptibility To Pseudorabies; SPONT, Spontenous Cell Proliferation; IMMa, Stress-Induced Alterations In Mitogen Induced IL-2 Activity; PWM, PWM Induced Cell Proliferation; IMMb, Stress-Induced Alteration In Number Of Neutrophils; These seven QTLs belong to two big categories of the health traits: WBC, SPONT, IMMa, PWM, IMMb are grouped into the category of "Pathogen Immune Capacity"; ECF18R and PRV are grouped into the category of "Disease Resistance".